JOEL SMITH: Open Payments
NPI 1134239270 · OOLTEWAH, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,264 in 125 payments from 27 companies in 2025. Trend: 2023 $2,041 · 2024 $1,645 · 2025 $2,264
Food & beverage: $2,264
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 30 | $465 |
| Novartis Pharmaceuticals Corporation | 11 | $246 |
| PFIZER INC. | 14 | $226 |
| AstraZeneca Pharmaceuticals LP | 6 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $135 |
| Abbott Laboratories | 6 | $131 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $101 |
| Boston Scientific Corporation | 2 | $97 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
| Xeris Pharmaceuticals, Inc. | 3 | $69 |
Products named: LEQVIO, Rybelsus, Ozempic, Kerendia, FREESTYLE LIBRE 3, NURTEC ODT, CAPLYTA, WaveWriter Alpha Prime 16.
Industry payments across TN — which companies pay providers there.
